Evgeni Chubar

484 total citations
15 papers, 124 citations indexed

About

Evgeni Chubar is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Evgeni Chubar has authored 15 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 8 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Evgeni Chubar's work include Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Blood groups and transfusion (3 papers). Evgeni Chubar is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Protein Degradation and Inhibitors (4 papers) and Blood groups and transfusion (3 papers). Evgeni Chubar collaborates with scholars based in Israel, United States and Canada. Evgeni Chubar's co-authors include Noa Lavi, Moshe E. Gatt, Yaël C. Cohen, Irit Avivi, Pia Raanani, Hila Magen, Tamar Tadmor, Eli Muchtar, Ory Rouvio and Tzippy Shochat and has published in prestigious journals such as Blood, British Journal of Haematology and Frontiers in Oncology.

In The Last Decade

Evgeni Chubar

13 papers receiving 122 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evgeni Chubar Israel 7 95 69 44 43 24 15 124
Laure Morisset France 4 70 0.7× 42 0.6× 39 0.9× 34 0.8× 11 0.5× 5 119
Lene Hyldahl Ebbesen Denmark 8 152 1.6× 100 1.4× 77 1.8× 24 0.6× 12 0.5× 13 215
K R Reynolds United States 5 104 1.1× 66 1.0× 72 1.6× 11 0.3× 24 1.0× 10 190
Gabriela Borsaru Romania 7 111 1.2× 105 1.5× 28 0.6× 38 0.9× 7 0.3× 11 169
Erika Morsia Italy 6 136 1.4× 67 1.0× 71 1.6× 32 0.7× 7 0.3× 26 169
Denise Wolleschak Germany 9 85 0.9× 84 1.2× 86 2.0× 19 0.4× 8 0.3× 25 157
Faye Feller United States 7 124 1.3× 110 1.6× 97 2.2× 18 0.4× 27 1.1× 25 187
Fabrizia Favale France 4 82 0.9× 43 0.6× 43 1.0× 11 0.3× 10 0.4× 8 127
Monika Kutyna Australia 5 114 1.2× 47 0.7× 68 1.5× 13 0.3× 30 1.3× 21 156
Immacolata Attolico Italy 6 82 0.9× 27 0.4× 47 1.1× 44 1.0× 7 0.3× 17 146

Countries citing papers authored by Evgeni Chubar

Since Specialization
Citations

This map shows the geographic impact of Evgeni Chubar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgeni Chubar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgeni Chubar more than expected).

Fields of papers citing papers by Evgeni Chubar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evgeni Chubar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgeni Chubar. The network helps show where Evgeni Chubar may publish in the future.

Co-authorship network of co-authors of Evgeni Chubar

This figure shows the co-authorship network connecting the top 25 collaborators of Evgeni Chubar. A scholar is included among the top collaborators of Evgeni Chubar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evgeni Chubar. Evgeni Chubar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
White, Darrell, Gary J. Schiller, Sumit Madan, et al.. (2024). Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma. Frontiers in Oncology. 14. 1352281–1352281. 3 indexed citations
2.
White, Darrell, Muhamed Baljević, Gary J. Schiller, et al.. (2023). P982: EFFICACY AND SAFETY OF 40 MG VS 60 MG OF ONCE WEEKLY SELINEXOR IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM). HemaSphere. 7(S3). e899038f–e899038f. 1 indexed citations
3.
4.
5.
Cohen, Yaël C., Hila Magen, Noa Lavi, et al.. (2020). Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study. Annals of Hematology. 99(6). 1273–1281. 13 indexed citations
6.
7.
Raanani, Pia, David Lavie, Yulia Volchek, et al.. (2018). Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study. Clinical Lymphoma Myeloma & Leukemia. 18(7). e295–e301. 16 indexed citations
8.
Steinberg‐Shemer, Orna, Orly Dgany, Joanne Yacobovich, et al.. (2018). Targeted next generation sequencing for the diagnosis of patients with rare congenital anemias. European Journal Of Haematology. 101(3). 297–304. 24 indexed citations
9.
Cohen, Yaël C., Hila Magen, Noa Lavi, et al.. (2018). Time to Progression Post-Induction Predicts Outcomes of Ixazomib Based Therapy for Relapsed/Refractory Myeloma: Real World Data from a Multi-Site Israeli Registry Study. Blood. 132(Supplement 1). 1972–1972. 1 indexed citations
10.
11.
Ellis, Martin, Noa Lavi, Elena Mishchenko, et al.. (2015). Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice. Leukemia Research. 39(11). 1154–1158. 7 indexed citations
12.
Gatt, Moshe E., Izhar Hardan, Evgeni Chubar, et al.. (2015). Outcomes of light‐chain amyloidosis patients treated with first‐line bortezomib: a collaborative retrospective multicenter assessment. European Journal Of Haematology. 96(2). 136–143. 11 indexed citations
13.
Muchtar, Eli, Moshe E. Gatt, Ory Rouvio, et al.. (2015). Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational study. British Journal of Haematology. 172(1). 89–96. 31 indexed citations
14.
Aviv, Ariel, Evgeni Chubar, & Michael Bennett. (2014). Successful treatment of pure red cell aplasia secondary to chronic lymphocytic leukemia using cyclosporine A.. PubMed. 16(1). 63–5. 1 indexed citations
15.
Ellis, Martin, Noa Lavi, Elena Mishchenko, et al.. (2014). Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting. Blood. 124(21). 1830–1830. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laure Morisset Breakdown of academic impact, for papers by Lene Hyldahl Ebbesen Breakdown of academic impact, for papers by K R Reynolds Breakdown of academic impact, for papers by Gabriela Borsaru Breakdown of academic impact, for papers by Erika Morsia Breakdown of academic impact, for papers by Denise Wolleschak Breakdown of academic impact, for papers by Faye Feller Breakdown of academic impact, for papers by Fabrizia Favale Breakdown of academic impact, for papers by Monika Kutyna Breakdown of academic impact, for papers by Immacolata Attolico
Rankless by CCL
2026